The job offer seems like a dream come true, but as Doctor Jack Goodman is about to discover, initial impressions can be deceiving. OncoGene has found the cure to cancer, and everything is on pace to launch the novel therapy as the FDA fast-tracks the approval process. The results of the clinical trial have been dramatic, better than a ninety percent cure rate. Jack, however, is about to be challenged in an unexpected way. Someone is holding back critical clinical trial results. As Jack and his colleague Sarah Friedman search for answers, their lives are suddenly at risk. Suddenly, it's become a fight for survival.